Companies / Aardvark Therapeutics
Aardvark Therapeutics
United States
Aardvark Therapeutics is a clinical-stage biopharmaceutical company developing novel, small-molecule therapies designed to inhibit hunger and treat metabolic diseases.
Aardvark Therapeutics, based in United States, has 1 investor on file, among them LG Technology Ventures. Its site was last checked 6 Nov 2026: site answers.
SEC Form D filings
3 filingsFiled by Aardvark Therapeutics, Inc. with the SEC. A Form D reports a private offering; it is not a priced round.
Investors
1 investor on file| Investor | Evidence | Type |
|---|---|---|
| Portfolio page | Corporate VC |
In the news
1 headline naming Aardvark TherapeuticsEach headline is matched with evidence and opens on its outlet. Some come through the GDELT Project.
More from LG Technology Ventures
86 companies on its checked portfolioIts portfolio leans to AI & Machine Learning (29%), Enterprise Software (12%), Industrial & Manufacturing (11%).
See LG Technology Ventures' full profile · Who invests alongside it
A company is shown only after its own site answers and carries its name. Sites are checked again on a schedule, because domains lapse and get bought. Round stages and dates come from Fundup AI; investor links come from portfolio pages and rounds; other facts name their source when you point at them. How we grade the data
Get Aardvark Therapeutics and its investors as data
Look up any company's investors, or any investor's full portfolio, through one API key or MCP. A free account also opens Ask AI searches and alerts when LG Technology Ventures adds a company.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/companies/aardvarktherapeutics.com/investors
# also
GET /v1/companies/aardvarktherapeutics.com
GET /v1/companies/aardvarktherapeutics.com/news